Beta-blockers Associated with a Mortality Benefit in Patients with Systolic Dysfunction and Elevated Serum Bilirubin

BACKGROUND: Hyperbilirubinemia is associated with increased mortality in heart failure (HF) patients. We evaluated the impact of evidence-based medical therapy, in particular beta-blocker on the survival of patients with HF and hyperbilirubinemia. METHODS AND RESULTS: We reviewed the charts of all p...

Descripción completa

Detalles Bibliográficos
Autores principales: Labos, Christopher, Nguyen, Vivian, Giannetti, Nadia, Huynh, Thao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Open 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4168649/
https://www.ncbi.nlm.nih.gov/pubmed/25246987
http://dx.doi.org/10.2174/1874192401408010076

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4168649/
https://www.ncbi.nlm.nih.gov/pubmed/25246987
http://dx.doi.org/10.2174/1874192401408010076

Ejemplares similares